In this study the in vivo platelet survival in 43 patients who received 69 transfusions of 51Cr-labeled platelets has been investigated for the influence of
(1) HL-A compatibility between the donor(s) and the recipient of platelets and (2) presence or absence of lymphocytotoxic antibodies in patients' serum at the time of platelet infusion.
In vivo survival has been measured in terms of per cent recovery (%R) and half-life in hours (t ) of infused 5tCr-labeled platelets. Table  5 , but have been excluded in 
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